STEVE ROBERSON: Open Payments
NPI 1669668422 · NATCHEZ, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$106 in 6 payments from 6 companies in 2025. Trend: 2023 $579 · 2024 $344 · 2025 $106
Food & beverage: $106
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $22 |
| CSL Behring | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| ABIOMED | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: Veozah, Andembry, JARDIANCE, TRELEGY ELLIPTA, OTEZLA.
Industry payments across MS — which companies pay providers there.
